Getinge 2022 Annual Report
Getinge 2022 Annual Report
Introduction
Strategy
Corporate Governance
Annual Report
Sustainability Report
Other information
Contents
Business areas
The Group's 20 largest markets
ACUTE CARE THERAPIES, SEK M
2022
2021
2020
2019
2018
2022
2021
2020
Order intake
16,108
15,335
19,208
14,778
13,069
SEK M
%
#
SEK M
%
#
SEK M
%
#
Net sales
15,285
15,527
18,719
14,637
13,013
US
China
10,143
35.9%
1
9,040
33.4%
1
9,948
33.4%
1
2,610
9.2%
2
2,639
9.8%
2
2,186
7.3%
2
Adjusted gross profit
9,174
9,596
11,536
8,660
7,627
Germany
1,631
5.8%
3
1,997
7.4%
3
2,016
6.8%
3
Margin, %
60.0
61.8
61.6
59.2
58.6
Japan
1,254
4.4%
4
1,298
4.8%
4
1,476
5.0%
4
Adjusted EBITDA
4,274
5,272
6,833
4,026
3,259
France
1,251
4.4%
5
1,272
4.7%
5
1,288
4.3%
5
Margin, %
28.0
34.0
36.5
27.5
25.0
United Kingdom
949
3.4%
6
989
3.7%
6
977
3.3%
7
Italy
849
3.0%
7
818
3.0%
7
1,011
3.4%
6
Depreciation, amortization and write-downs of tangible and
-872
-828
-1,002
-916
-726
Spain
649
2.3%
intangible assets
Canada
606
2.1%
Adjusted EBITA
3,402
Margin, %
22.3
4,444
28.6
5,831
31.1
3,110
2,533
Australia
582
2.1%
21.2
19.5
Sweden
549
1.9%
India
534
1.9%
Netherlands
496
1.8%
LIFE SCIENCE, SEK M
2022
2021
2020
2019
2018
Hong Kong
354
1.2%
Order intake
Net sales
3,932
4,120
3,413
2,640
2,295
Korea, Republic of
304
1.1%
89012345
530
2.0%
11
651
2.2%
620
2.3%
8
754
2.5%
558
2.1%
10
705
2.4%
11
492
1.8%
12
804
2.7%
579
2.1%
9
384
1.3%
399
1.5%
13
522
1.8%
309
1.1%
14.
329
1.1%
267
1.0%
16
305
1.0%
(South)
4,026
3,558
2,854
2,487
2,194
Belgium
296
1.0%
16
303
1.1%
15
460
1.5%
Adjusted gross profit
1,548
1,492
1,176
962
815
Switzerland
284
1.0%
17
260
1.0%
17
322
1.1%
Margin, %
38.5
41.9
41.2
38.7
37.1
Brazil
274
1.0%
18
206
0.8%
23
237
0.8%
Adjusted EBITDA
801
870
522
432
348
Denmark
265
0.9%
19
241
0.9%
18
231
0.8%
23
Margin, %
19.9
24.5
18.3
17.4
15.9
Thailand
241
0.9%
20
237
0.9%
20
257
0.9%
19085368 1222
11
14
17
Depreciation, amortization and write-downs of tangible and
-151
-141
-128
-109
-71
intangible assets
Adjusted EBITA
650
729
393
323
277
Margin, %
16.1
20.5
13.8
13.0
12.6
SURGICAL WORKFLOWS, SEK M
2022
2021
2020
2019
2018
Order intake
9,581
8,803
7,948
9,414
8,983
Net sales
8,981
7,965
8,246
9,435
8,965
Adjusted gross profit
3,639
3,304
3,163
3,779
3,501
Margin, %
40.5
41.5
38.4
40.1
39.1
Adjusted EBITDA
1,127
949
495
863
567
Margin, %
12.5
11.9
6.0
9.1
6.3
Depreciation, amortization and write-downs of tangible and
-577
-559
-622
-641
-425
intangible assets
Adjusted EBITA
549
390
-127
222
142
Margin, %
6.1
4.9
-1.5
2.4
1.6
181View entire presentation